AI-powered search

Does COVID-19 Infection Raise the Odds of Alopecia Areata?

Patients with COVID-19 have a significantly higher incidence of AA than controls, irrespective of clinical subtype

By Dermsquared Editorial Team | January 10, 2024

WEDNESDAY, Jan. 10, 2024 -- The incidence and prevalence of alopecia areata (AA) are increased after COVID-19 infection, according to a research letter published online Jan. 10 in JAMA Dermatology.

Jong-Seung Kim, M.D., Ph.D., from the Jeonbuk National University Medical School in Jeonju, South Korea, and colleagues conducted a propensity score-matched, nationwide, population-based cohort study to examine the association between COVID-19 and AA. The cohort included 259,369 patients with COVID-19 and 259,369 uninfected controls.

The researchers found that the cohort with COVID-19 had an increased risk for telogen effluvium (positive control) compared with the uninfected cohort (adjusted hazard ratio, 6.40); the incidence of negative control outcomes was not different between the groups. Patients with COVID-19 had a significantly higher incidence of AA than controls (43.19 versus 23.61 per 10,000 person-years [PY]), regardless of clinical subtype (adjusted hazard ratio, 1.82). A higher incidence of patchy AA and alopecia totalis and alopecia universalis (AT/AU) was seen for patients with COVID-19 (35.94 and 7.24 per 10,000 PY, respectively) than controls (19.43 and 4.18 per 10,000 PY, respectively). In all groups older than 20 years, the incidence of AA after COVID-19 was significantly increased, with higher risk seen for both male and female patients. The prevalence of AA and AT/AU was significantly higher for patients with COVID-19 (70.53 and 12.39 per 10,000 PY, respectively) than controls (52.37 and 8.97 per 10,000 PY, respectively).

"This study suggested an epidemiologic association between COVID-19 and AA," the authors write. "Further studies are necessary to validate the association between different populations and elucidate the causal relationship between the two conditions."


The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us


Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved